Synopsis of recent research by authors named "Su-Wen Su"
- Su-Wen Su's recent research primarily focuses on the mechanisms underlying doxorubicin resistance in breast cancer, exploring various signaling pathways such as FABP5/PPARγ and miR-34a-5p/NOTCH1 that could serve as potential therapeutic targets.
- The studies highlight the promising role of natural compounds like berberine and atorvastatin in mitigating the side effects of doxorubicin, including hepatotoxicity and cardiotoxicity, thus enhancing the clinical utility of this chemotherapy agent.
- Su-Wen Su also investigates cardiotoxicity due to traditional treatments, contributing to a broader understanding of the protective effects of natural substances against chemotherapy-induced damage.
